RESUMO
The entero-mammary pathway is a specialized route that selectively translocates bacteria to the newborn's gut, playing a crucial role in neonatal development. Previous studies report shared bacterial and archaeal taxa between human milk and neonatal intestine. However, the functional implications for neonatal development are not fully understood due to limited evidence. This study aimed to identify and characterize the microbiota and metabolome of human milk, mother, and infant stool samples using high-throughput DNA sequencing and FT-ICR MS methodology at delivery and 4 months post-partum. Twenty-one mothers and twenty-five infants were included in this study. Our results on bacterial composition suggest vertical transmission of bacteria through breastfeeding, with major changes occurring during the first 4 months of life. Metabolite chemical characterization sheds light on the growing complexity of the metabolites. Further data integration and network analysis disclosed the interactions between different bacteria and metabolites in the biological system as well as possible unknown pathways. Our findings suggest a shared bacteriome in breastfed mother-neonate pairs, influenced by maternal lifestyle and delivery conditions, serving as probiotic agents in infants for their healthy development. Also, the presence of food biomarkers in infants suggests their origin from breast milk, implying selective vertical transmission of these features.
Assuntos
Aleitamento Materno , Fezes , Microbioma Gastrointestinal , Leite Humano , Humanos , Leite Humano/microbiologia , Leite Humano/química , Feminino , Recém-Nascido , Microbioma Gastrointestinal/fisiologia , Fezes/microbiologia , Lactente , Adulto , Metaboloma , Bactérias/metabolismo , Bactérias/classificação , Bactérias/genética , Masculino , MãesRESUMO
Introduction. Frailty syndrome generates a high risk of adverse outcomes and mortality, and its prevalence is elevated in patients with end-stage kidney disease. Few studies have reported the prevalence and outcomes of frailty in populations from less developed countries. Objective. To identify the clinical outcomes and factors associated with the frailty syndrome in patients with stage five chronic kidney disease who started renal replacement therapy both hemodialysis and peritoneal dialysis in a dialysis center in Bucaramanga, Colombia. Materials and methods. This was a prospective study of patients with end-stage kidney disease who initiated dialysis at a center in Colombia and had a twelve-month follow-up. Results. The overall frailty prevalence was 50.47% and two out of three patients older than 65 years had the syndrome. We found significantly higher followup mortality among patients with frailty: odds ratio of 2.95 (CI: 1.07- 8.13; p=0.036) in unadjusted analysis. Conclusions. Literature shows that compared to developed nations, Latin American adults are facing a higher prevalence of chronic diseases, and frailty syndrome is increasing. In this study, according to the FRAIL scale, having a frailty syndrome predicts a higher mortality; hypoalbuminemia and low creatinine levels at the beginning of dialysis could act as predictors of its diagnosis.
Introducción. El síndrome de fragilidad implica un alto riesgo de desenlaces adversos y mortalidad, y tiene una prevalencia elevada en pacientes con enfermedad renal en etapa terminal. Hay pocos estudios que investiguen la prevalencia y los desenlaces de este síndrome de fragilidad en las poblaciones de los países en desarrollo. Objetivo. Identificar los desenlaces clínicos y los factores asociados al síndrome de fragilidad en los pacientes con enfermedad renal crónica en estadio cinco que inician terapia de reemplazo renal con hemodiálisis o diálisis peritoneal en un centro de diálisis de Bucaramanga, Colombia. Materiales y métodos. Se trató de un estudio prospectivo de pacientes con enfermedad renal en etapa terminal que iniciaron diálisis en un centro de Colombia y a quienes se les hizo seguimiento durante doce meses. Resultados.La prevalencia global del síndrome de fragilidad fue del 50,47 % y dos de cada tres pacientes mayores de 65 años lo presentaban. Se encontró una mortalidad significativamente mayor entre los pacientes con síndrome de fragilidad: razón de probabilidad de 2,95 (IC:1,07-8,13; p=0,036) en el análisis no ajustado. Conclusiones. La literatura muestra que, en comparación con los países desarrollados, los adultos latinoamericanos presentan una mayor prevalencia de enfermedades crónicas y un aumento progresivo del síndrome de fragilidad. En este estudio, la fragilidad según la escala FRAIL predijo una mayor mortalidad. Además, la hipoalbuminemia y los niveles bajos de creatinina al inicio de la diálisis podrían actuar como elementos predictores de su diagnóstico.
Assuntos
Diálise , Fragilidade , Nefropatias , Terapia de Substituição RenalRESUMO
INTRODUCTION: Frailty syndrome generates a high risk of adverse outcomes and mortality, and its prevalence is elevated in patients with end-stage kidney disease. Few studies have reported the prevalence and outcomes of frailty in populations from less developed countries. OBJECTIVE: To identify the clinical outcomes and factors associated with the frailty syndrome in patients with stage five chronic kidney disease who started renal replacement therapy - both hemodialysis and peritoneal dialysis- in a dialysis center in Bucaramanga, Colombia. MATERIALS AND METHODS: This was a prospective study of patients with end-stage kidney disease who initiated dialysis at a center in Colombia and had a twelve-month follow-up. RESULTS: The overall frailty prevalence was 50.47% and two out of three patients older than 65 years had the syndrome. We found significantly higher followup mortality among patients with frailty: odds ratio of 2.95 (CI: 1.07- 8.13; p=0.036) in unadjusted analysis. CONCLUSIONS: Literature shows that compared to developed nations, Latin American adults are facing a higher prevalence of chronic diseases, and frailty syndrome is raising. In this study, according to the FRAIL scale, having a frailty syndrome predicts a higher mortality; hypoalbuminemia and low creatinine levels at the beginning of dialysis could act as predictors of its diagnosis.
Introduction. Frailty syndrome generates a high risk of adverse outcomes and mortality, and its prevalence is elevated in patients with end-stage kidney disease. Few studies have reported the prevalence and outcomes of frailty in populations from less developed countries.Objective. To identify the clinical outcomes and factors associated with the frailty syndrome in patients with stage five chronic kidney disease who started renal replacement therapy both hemodialysis and peritoneal dialysis in a dialysis center in Bucaramanga, Colombia.Materials and methods. This was a prospective study of patients with end-stage kidney disease who initiated dialysis at a center in Colombia and had a twelve-month follow-up. Results. The overall frailty prevalence was 50.47% and two out of three patients older than 65 years had the syndrome. We found significantly higher followup mortality among patients with frailty: odds ratio of 2.95 (CI: 1.07- 8.13; p=0.036) in unadjusted analysis.Conclusions. Literature shows that compared to developed nations, Latin American adults are facing a higher prevalence of chronic diseases, and frailty syndrome is increasing. In this study, according to the FRAIL scale, having a frailty syndrome predicts a higher mortality; hypoalbuminemia and low creatinine levels at the beginning of dialysis could act as predictors of its diagnosis.
Assuntos
Fragilidade , Falência Renal Crônica , Adulto , Idoso , Humanos , Fragilidade/epidemiologia , Fragilidade/diagnóstico , Diálise Renal/efeitos adversos , Idoso Fragilizado , Estudos Prospectivos , América Latina/epidemiologia , Falência Renal Crônica/complicações , Falência Renal Crônica/epidemiologia , Falência Renal Crônica/terapiaRESUMO
Introduction: The mother's colostrum carries immunological components, such as cytokines and immunoglobulins (Igs), derived from the maternal circulation with bacteriostatic properties. Objective: The objective of this study was to evaluate the effect of oropharyngeal administration of colostrum (OPAC) vs. placebo in the first 4 days of life in premature newborns ≤32 weeks of gestation on serum Ig concentration, neonatal morbidity, and total days of hospitalization. Hypothesis: The OPAC increases serum Igs and decreases morbidity and total days of hospitalization. Materials and Methods: A double-blind randomized controlled trial was carried out. Participants were randomly assigned to one of the two groups, namely, group 1: placebo (P) (n = 50) and group 2: colostrum (C) (n = 46). A blood sample was obtained at baseline and 7 and 28 days of life to quantify immunoglobulin G (IgG), immunoglobulin A (IgA), and IgM. Results: The C group showed an increase in serum IgA on day 28 expressed as median and [interquartile range]; C: 25 [12-35] vs. P: 11 [8-18], p < 0.001. There were no significant differences in neonatal morbidity. Newborns in the colostrum group showed the completed enteral feeding earlier (days), C: 13.9 ± 7 vs. P: 17.4 ± 8.4, p < 0.04; they reached the birth weight earlier, C: 10.9 ± 2.8 vs. P: 12.9 ± 4, p < 0.01, and had less days of hospitalization, C: 60.2 ± 33.8 vs. P: 77.2 ± 47.3, p < 0.04. Neonatal mortality was lower in the colostrum group than the placebo group 0% vs. 12%, respectively, without a statistical difference (p = 0.06). Conclusion: In premature newborns ≤32 weeks of gestation, the OPAC within 4 days after birth increases serum IgA concentration at day 28 compared to placebo. Similarly, OPAC decreased the days to complete enteral feeding and reach the birth weight and total days of hospitalization. Clinical Trial Registration: [https://clinicaltrials.gov/ct2/show/NCT03578341], identifier: [NCT03578341].
Assuntos
Antioxidantes/uso terapêutico , Suplementos Nutricionais , Recém-Nascido de muito Baixo Peso , Retinopatia da Prematuridade/prevenção & controle , Vitamina E/uso terapêutico , Administração Oral , Antioxidantes/administração & dosagem , Método Duplo-Cego , Esquema de Medicação , Feminino , Humanos , Recém-Nascido , Masculino , Estresse Oxidativo , Soluções , Vitamina E/administração & dosagemRESUMO
Introducción: La corioamnionitis es común durante el embarazo y se asocia con diversas complicaciones perinatales; entre los problemas neonatales más frecuentes están: parto pretérmino, sepsis neonatal, enfermedad pulmonar crónica, lesión cerebral secundaria a infección y trastornos del desarrollo neurológico. Es necesario conocer el riesgo de sepsis neonatal temprana en recién nacidos hijos de madres con corioamnionitis, con la intención de plantear estrategias para su prevención y tratamiento. Objetivos: Determinar el grado de asociación entre la corioamnionitis materna y la aparición de sepsis neonatal temprana. Métodos: Se realizó un estudio de casos y controles donde se incluyeron 148 pacientes divididos en dos grupos: grupo I, los casos, hijos de madres con corioamnionitis (n = 74), y grupo II, control, neonatos sin antecedente de corioamnionitis materna (n = 74). Resultados: El grupo de madres con corioamnionitis tuvo menor control prenatal y sus recién nacidos, a pesar de haber recibido antibiótico profiláctico, tuvieron una mayor frecuencia de sepsis y problemas respiratorios. Conclusiones: Los hijos de madres con corioamnionitis tienen un incremento en el riesgo de presentar sepsis neonatal temprana.
Introduction: Chorioamnionitis is common during pregnancy and associated with several perinatal complications, including postpartum infection and sepsis. Among the most frequent neonatal complications associated to chorioamnionitis are: preterm delivery, neonatal sepsis, chronic lung disease, brain injury secondary to infection, and other neurodevelopmental disorders. It is necessary to know what the risk is of early-onset neonatal sepsis in newborns to mothers with chorioamnionitis. Objective: Determine whether maternal chorioamnionitis has an association with early-onset neonatal sepsis. Methods: We performed a case-control study, in which we included 148 patients divided in two groups: group I, cases (n = 74) and group II, controls (n = 74). The sample size was calculated through difference of proportions. Results: The group of mothers with chorioamnionitis had less prenatal care, and their newborns had a larger number of infections and respiratory problems despite the indication of prophylactic antibiotic schemes. Conclusions: Newborn infants to mother with chorioamnionitis have an increased risk of early neonatal sepsis, despite the use of prophylactic antibiotics.
RESUMO
Introducción: En los últimos años ha habido un incremento de recién nacidos cercanos a término; esta prematurez tardía se asocia con un aumento en la morbilidad y mortalidad neonatal, por lo que es interesante conocer las diferencias en la morbilidad de este grupo de pacientes, en comparación con los recién nacidos a término. Objetivo: Evaluar la morbimortalidad temprana y durante el primer mes de vida del prematuro tardío en comparación con el recién nacido a término. Material y métodos: Se realizó un estudio comparativo de dos cohortes de recién nacidos. Grupo 1: recién nacidos prematuros tardíos de 34 a 36.6 semanas de gestación, y Grupo 2: recién nacidos a término. Se compararon 15 variables relacionadas a morbimortalidad. Se utilizó estadística descriptiva, para la comparación entre grupos t de Student y para comparar la morbilidad se determinó el riesgo relativo con el 95% de intervalo de confianza. Resultados: Se incluyeron 59 prematuros tardíos y 69 nacidos a término. De los factores maternos estudiados no hubo diferencias significativas. Respecto a los neonatos, existió un mayor riesgo del prematuro tardío para hiperbilirrubinemia (OR: 1.7 con IC 95% 1.1-2.65, reflujo gastroesofágico 1.8 con IC 95% 1.1-2.9 y dificultad en la alimentación (OR 1.66 con IC 95% 1.14-2.4). Conclusiones: Los riesgos de morbilidad encontrados en el prematuro tardío son aquellos que se presentan por su propia prematurez. No se encontró morbilidad en el prematuro tardío, secundaria a patología materna asociada.
Introduction: In recent years there has been an increase in the number of births of infants near term; this late prematurity is associated with increased neonatal morbidity and mortality, so it is important to know the differences in morbidity in this group of patients compared with term newborns, during the first month of life. Objective: To evaluate the early morbidity and during the first month of life of late preterm compared with term infants. Material and methods: We performed a comparative study of two cohorts of infants. Cohort 1: Late preterm infants from 34 to 36.6 weeks of gestation and Cohort 2; term infants. The morbidity was recorded during the first month of life, 15 variables were measure. We used descriptive statistic, for comparison between groups Student's t and to compare morbidity between groups the relative risk with 95% confidence interval. Results: We included 59 late preterm and 69 term infants. Of the maternal factors studied no statistically significant difference was found; respect to neonatal morbidity, we identified a great risk in the late preterm risk for hyperbilirubinemia (OR 1.7, CI 95% 1.1-2.65), gastroesophageal reflux (OR 1.8, CI 95% 1.1-289) and feeding difficulties (OR: 1.66, CI 95% 1.14-2.42). Conclusions: The risk of morbidity in late preterm found are those related to their own prematurity. In this study, there was no pathology associated with maternal morbidity in late preterm.
RESUMO
Este trabajo analiza algunas dimensiones del proyecto de trabajo de jóvenes escolarizados: expectativas y aspiraciones, caracteristicas personales de iniciativa, estrategias de búsqueda de trabajo, valores laborales, definiciones del trabajo y percepción de recursos y obstáculos para la inserción laboral. La metodología es cuantitativa. Se tomaron 1546 cuestionarios autoadministrables a alumnos de escuelas medias públicas de la Ciudad Autónoma de Buenos Aires: 707 mujeres y 839 varones. El promedio de edad en primer año fue de 14 años; en tercer año de 16 años y en quinto año de 18 años. Se han realizado análisis descriptivos, análisis de varianzas (ANOVA) y utilizado pruebas no paramétricas. En este trabajo se han delimitado importantes dimensiones que inluyen en la construcción de los proyectos laborales y se han encontrado variables potentes para explicar las diferencias al interior de la población estudiada: sexo, especialidad, experiencia laboral, año de la trayectoria escolar y repetición.
This paper analyzes some dimensions of work projects of youth students: expectations and aspirations, personal characteristics of initiative, work search strategies, work values, deinitions of work and perception of resources and obstacles for labor insertion. The methodology is quantitative. 1546 self-managing questionnaires to students from public secondary schools of the C.A.B.A. were taken: 707 women and 839 men. The age's average in the irst year was of 14 years old; in the third year of 16 years old and in the ifth year of 18 years old. Descriptive analyses and analyses of variances have been made (ANOVA) and non-parametric tests were applied. In this work important dimensions that inluence in the construction of work projects have been delimited and there have been found powerful variables to explain the differences within the studied population: sex, specialty, work experience, year of the scholastic trajectory and repetition.
RESUMO
Introducción. La mortalidad neonatal es un indicador sensible y específico que nos permite conocer el estado de salud de un país y plantear estrategias para mejorarlo. Resulta de una cadena compleja de determinantes como los biológicos, los socioeconómicos y los de salud. El objetivo de este trabajo fue conocer la tasa de mortalidad neonatal general, por peso y edad gestacional, en un instituto de tercer nivel de atención durante 2007 y 2008. Métodos. Se analizaron todos los casos provenientes del comité de mortalidad perinatal y neonatal, de 2007 y 2008, desde 22 semanas de gestación en adelante. El análisis estadístico se realizó mediante medidas de tendencia central y dispersión para las variables cuantitativas y para las variables cualitativas frecuencia, porcentaje, χ² y razón de momios con nivel de significación estadística < 0.05. Resultados. La tasa de mortalidad para el año 2007 fue de 17.7 × 1000 nacidos vivos y para el 2008 de 19.7 × 1000 nacidos vivos. En relación con el peso y con la edad gestacional no se encontró aumento de riesgo al comparar los resultados de ambos años. Las malformaciones ocuparon el mayor porcentaje entre las causas de defunción. Conclusiones. Las tasas de mortalidad en 2007 y 2008 fueron de 17.7 y 19.7 × 1000 nacidos vivos, respectivamente. Las principales causas de defunción fueron las malformaciones cardiacas.
Background. Mortality is a sensitive and specific indicator for determining the health status of a country in order to implement improvement strategies. It is the result of biological, social, economic and health factors. The aim of this study was to determine neonatal general mortality and its relationship with weight and gestational age at a third-level health institution from 2007 to 2008. Methods. We analyzed all patients >22 weeks of gestational age from the perinatal mortality service. Statistical analysis was done using measures of central tendency and dispersion for quantitative variables and χ2, percentage and frequency for qualitative variables; odds ratios were calculated with significance level <0.05. Results. The mortality rate for 2007 was 17.7 per 1000 live births, and for 2008 it was 19.7 per 1000 live births. When we compared both years, we did not find an increased risk for weight and gestational age. Malformations occupied the largest causes of death. Conclusions. For years 2007 and 2008, mortality rates were 17.7 and 19.7 per 1000 live births, respectively, and the main cause of deaths were cardiac malformations.
RESUMO
Este trabajo se focaliza en el estudio de las significaciones del estudio y de la escuela, en jóvenes que se encuentran cursando el nivel medio, considerando tres momentos de la trayectoria escolar: primero, tercero y quinto año. La metodología de la investigación es cuantitativa. Se tomaron 1546 cuestionarios autoadministrables a alumnos de escuelas medias públicas de la C.A.B.A., de los cuales 707 eran mujeres y 839 varones. El promedio de edad en primer año fue de 14 años; en tercer año de 16 años y en quinto año de 18 años. Las pruebas utilizadas fueron Significación del Estudio y Significación de la Escuela. Utilizando el test no paramétrico y la prueba de comparaciones múltiples de Kruskal Wallis, se encontró que la significación del estudio y de la escuela de la población de primer año es distinta a la de tercero y quinto.
This paper focuses in the study of the meanings of study and school in young people who are attending middle level, considering three moments of the scholastic trajectory: first, third and fifth year. The investigation's methodology is quantitative.1546 self-managing questionnaires were taken to students attending public secondary schools of the C.A.B.A, of which 707 were women and 839 were men. The average age in first year was of 14 years; in third year of 16 years and fifth year of 18 years. Using the non-parametric test and the test of multiple comparisons of Kruskal Wallis, we conclude that the meaning of study and school of the population attending the first year is different from the one of third and fifth year.
RESUMO
Introducción. La prevalencia de colestasis neonatal varía del 7-57%. Parte del manejo incluye al ácido ursodesoxicólico (UDCA) y al fenobarbital, ambos con débil sustento en la literatura. El objetivo de este trabajo es comparar la efectividad del UDCA vs fenobarbital en la reducción de las cifras de bilirrubina directa, en recién nacidos prematuros con colestasis, con peso entre 1 000-2 000 g. Métodos. Se realizó un ensayo clínico aleatorizado cruzado en 18 pacientes. Cada individuo recibió al azar una de las dos intervenciones: UDCA (10 mg/kg/día c/12 h) o fenobarbital (a 3 mg/kg/día c/24 h) durante un período inicial de 7 días. Después de 7 días de lavado, se les asignó el tratamiento contrario. En total se realizaron 36 tratamientos. Se midieron bilirrubinas y pruebas de función hepática al inicio y final de cada tratamiento. El análisis se realizó por medio de medidas de tendencia central y de dispersión, de acuerdo al tipo de variable. Para la comprobación de hipótesis se realizó t pareada. Resultados. En el grupo que recibió UDCA a 10 mg/kg/día c/12 h por 7 días, disminuyeron las cifras de bilirrubina directa en 2.7 mg/dL (P<0.01). Conclusiones. Se recomienda el uso de UDCA a dosis de 10 mg/kg/día c/12 h por vía enteral como coadyuvante para el tratamiento de colestasis neonatal.
Background. The prevalence of neonatal cholestasis varies from 7-57%. Part of the treatment includes ursodeoxycholic acid (UDCA) and phenobarbital, both with little supporting evidence in the literature. We undertook this study to compare the effectiveness of phenobarbital vs. UDCA in reducing the direct serum bilirubin levels in patients with cholestasis and weighing from 1 000 to 2 000 g. Methods. Using a cross-randomized clinical trial, 18 patients were included with 36 treatments. Each subject randomly received one of the two interventions: UDCA (10 mg/kg/day) every 12 h or phenobarbital (3 mg/kg/day, every 24 h for 7 days) continuing with 7 days of wash-out to return to their initial state, and to subsequently receive the other treatment. At the beginning and at the end of the administration of each medication, bilirubin concentrations and hepatic test functions were measured. Central tendency and dispersion measurements were applied according to the type of variable. For hypothesis confirmation, paired t-test was carried out. Results. The obtained results indicate that with UDCA at a dose of 10 mg/kg/day every 12 h for 7 days, serum bilirubin levels decreased to 2.7 mg/dL (p <0.01). Phenobarbital had no effect in reducing bilirubin concentration. Conclusion. Use of UDCA is recommended at a dose of 10 mg/kg/dose every 12 h (PO) as a coadjuvant in the treatment of neonatal cholestasis.
RESUMO
Periodontal disease comprises a group of infections that lead to inflammation of the gingival and destruction of periodontal tissues and is accompanied by the loss of the alveolar bone with eventual exfoliation of the teeth. Porphyromonas gingivalis is a Gram-negative bacteria obtained from the periodontal pocket of patients with aggressive and chronic periodontitis. This bacteria presents in the external membrane lipopolysaccharide (LPS). Flavonoids are molecules obtained from plants and possess anti-inflammatory properties. Herein we characterize the effect of the flavonoids quercetin, genistein, luteolin, and quercetagetin on LPS-activated transduction mechanism regulation in human gingival fibroblasts (HGF). In this study, we investigated the role of the previously mentioned flavonoids on mitogen-activated protein kinase (MAPK) activation induced by LPS obtained from P. gingivalis. Our results showed that LPS treatment induces activation of extracellular signal related kinase 1/2 (ERK1/2), p38, and c-jun-NH(2)-terminal kinase (JNK). All flavonoids demonstrated an inhibitory effect on MAPK activation, interleukin, 1beta, and cyclooxygenase-2 (COX-2) expression, IL-1beta and prostaglandin E2 (PGE2) synthesis. The most active flavonoid was quercetagetin. Finally we found that the treatment with quercetagetin had no effect on cellular viability or in genetic material integrity.
Assuntos
Fibroblastos/metabolismo , Flavonoides/fisiologia , Gengiva/metabolismo , Lipopolissacarídeos/farmacologia , Transdução de Sinais/fisiologia , Células Cultivadas , Dinoprostona/biossíntese , Fibroblastos/efeitos dos fármacos , Gengiva/efeitos dos fármacos , Humanos , Fosfotransferases/efeitos dos fármacos , Fosfotransferases/metabolismo , Porphyromonas gingivalis/efeitos dos fármacos , Porphyromonas gingivalis/metabolismo , Transdução de Sinais/efeitos dos fármacos , Tagetes/fisiologiaRESUMO
INTRODUCTION: During the last decades the number of births in women with 35 or more years of age has increased approximately 35-50%. OBJECTIVE: To establish the neonatal morbidity associated with advanced maternal age, compared with mothers in the optimal reproductive stage. MATERIALS AND METHODS: This is a retrospective case-control survey. In 1999 we revised 210 records from neonates and mothers with 35 or more years of age (cases) and 210 records of neonates and mothers with age between 18 and 34 years (controls). The variability significance was established with t-student, X2 and risk with the probabilistic risk ratio. RESULTS: There was a significant difference in the socioeconomic and educational level. Advanced maternal age predisposed 2.43 times indication for cesarean section, increased the risk for gestational diabetes (11.35), toxemia (4.11) and in its severe form (2 times). Miscarriage menace (5.65 times). Lower birth weight (p < 0.007) and wet lung syndrome were more frequent in the advanced age group (p < 0.02). Risk for hypoglycemia was 1.62. There was also an increase in the risk for Trisomy 21 (p < 0.05) with an OR of 4 in cases. Genetic service evaluated 35 patients in the maternal advanced age group with an OR of 35. CONCLUSIONS: Advance maternal age increases maternal morbidity and the risk for preterm delivery, low birth weight, asymptomatic hypoglycemia, wet lung syndrome and risk for chromosomopathies.
Assuntos
Doenças do Recém-Nascido/epidemiologia , Idade Materna , Resultado da Gravidez/epidemiologia , Gravidez de Alto Risco , Adolescente , Adulto , Estudos de Casos e Controles , Cesárea/estatística & dados numéricos , Transtornos Cromossômicos/epidemiologia , Diabetes Gestacional/epidemiologia , Feminino , Humanos , Hipoglicemia/epidemiologia , Recém-Nascido de Baixo Peso , Recém-Nascido , Recém-Nascido Prematuro , Masculino , México/epidemiologia , Trabalho de Parto Prematuro/epidemiologia , Razão de Chances , Gravidez , Síndrome do Desconforto Respiratório do Recém-Nascido/epidemiologia , Estudos Retrospectivos , Risco , Fatores SocioeconômicosRESUMO
INTRODUCTION: During the last decades the number of births in women with 35 or more years of age has increased approximately 35-50. OBJECTIVE: To establish the neonatal morbidity associated with advanced maternal age, compared with mothers in the optimal reproductive stage. MATERIALS AND METHODS: This is a retrospective case-control survey. In 1999 we revised 210 records from neonates and mothers with 35 or more years of age (cases) and 210 records of neonates and mothers with age between 18 and 34 years (controls). The variability significance was established with t-student, X2 and risk with the probabilistic risk ratio. RESULTS: There was a significant difference in the socioeconomic and educational level. Advanced maternal age predisposed 2.43 times indication for cesarean section, increased the risk for gestational diabetes (11.35), toxemia (4.11) and in its severe form (2 times). Miscarriage menace (5.65 times). Lower birth weight (p < 0.007) and wet lung syndrome were more frequent in the advanced age group (p < 0.02). Risk for hypoglycemia was 1.62. There was also an increase in the risk for Trisomy 21 (p < 0.05) with an OR of 4 in cases. Genetic service evaluated 35 patients in the maternal advanced age group with an OR of 35. CONCLUSIONS: Advance maternal age increases maternal morbidity and the risk for preterm delivery, low birth weight, asymptomatic hypoglycemia, wet lung syndrome and risk for chromosomopathies.
Assuntos
Humanos , Masculino , Feminino , Gravidez , Recém-Nascido , Adolescente , Adulto , Doenças do Recém-Nascido/epidemiologia , Idade Materna , Resultado da Gravidez , Estudos de Casos e Controles , Cesárea/estatística & dados numéricos , Diabetes Gestacional , Hipoglicemia , Recém-Nascido de Baixo Peso , Recém-Nascido Prematuro , México , Trabalho de Parto Prematuro , Razão de Chances , Síndrome do Desconforto Respiratório do Recém-Nascido , Estudos Retrospectivos , Risco , Fatores Socioeconômicos , Transtornos Cromossômicos/epidemiologiaRESUMO
El síndrome de Sweet es una dermatosis caracterizada por la aparición brusca de placas eritematosas, dolorosas, predominantemente en cara, cuello y extremidades, acompañada de fiebre, leucocitosis a predominio neutrofílico y denso infiltrado dérmico leucocitario polimorfonuclear. Es bien conocida su relación con procesos neoplásicos malignos, motivo por el cuál es necesario el estudio minucioso y seguimiento del paciente. Presentamos un caso de leucemia mielomonocítica aguda asociada a ésta dermatosis, realizando una revisión bibliográfica del tema
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Síndromes Paraneoplásicas , Síndrome de Sweet/diagnóstico , Anticoncepcionais Orais , Lúpus Eritematoso Sistêmico/complicações , Doença Medicamentosa , Minociclina , Neoplasias , Complicações na Gravidez , Síndrome de Sweet/etiologia , Luz Solar , VacinasRESUMO
El síndrome de Sweet es una dermatosis caracterizada por la aparición brusca de placas eritematosas, dolorosas, predominantemente en cara, cuello y extremidades, acompañada de fiebre, leucocitosis a predominio neutrofílico y denso infiltrado dérmico leucocitario polimorfonuclear. Es bien conocida su relación con procesos neoplásicos malignos, motivo por el cuál es necesario el estudio minucioso y seguimiento del paciente. Presentamos un caso de leucemia mielomonocítica aguda asociada a ésta dermatosis, realizando una revisión bibliográfica del tema (AU)
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Síndrome de Sweet/diagnóstico , Síndromes Paraneoplásicas , Luz Solar/efeitos adversos , Doença Medicamentosa , Complicações na Gravidez , Neoplasias/complicações , Síndrome de Sweet/etiologia , Minociclina/efeitos adversos , Anticoncepcionais Orais/efeitos adversos , Vacinas/efeitos adversos , Lúpus Eritematoso Sistêmico/complicaçõesRESUMO
Presentamos un caso de un paciente de 14 años de edad, de sexo masculino, en quien los hallazgos clínicos, histopatológicos y de laboratorio confirmaron el diagnóstico de síndrome de Reiter. Realizamos una extensa revisión bibliográfica, en la cual observamos que aún hoy se discuten pautas diagnósticas, mecanismos fisiopatogénicos, terapéutica y asociaciones de este síndrome, particularmente en aquellos pacientes en quienes no se manifiesta totalmente
Assuntos
Humanos , Masculino , Adolescente , Artrite Reativa/diagnóstico , Artrite Reativa/tratamento farmacológico , Artrite Reativa/etiologia , Vacina BCG/efeitos adversos , Causalidade , Gonorreia/complicações , Metotrexato/uso terapêuticoRESUMO
Presentamos un caso de un paciente de 14 años de edad, de sexo masculino, en quien los hallazgos clínicos, histopatológicos y de laboratorio confirmaron el diagnóstico de síndrome de Reiter. Realizamos una extensa revisión bibliográfica, en la cual observamos que aún hoy se discuten pautas diagnósticas, mecanismos fisiopatogénicos, terapéutica y asociaciones de este síndrome, particularmente en aquellos pacientes en quienes no se manifiesta totalmente (AU)
Assuntos
Humanos , Masculino , Adolescente , Artrite Reativa/diagnóstico , Artrite Reativa/etiologia , Artrite Reativa/tratamento farmacológico , Antígeno HLA-B27 , Vacina BCG/efeitos adversos , Causalidade , Gonorreia/complicações , Metotrexato/uso terapêuticoRESUMO
Se presenta un paciente en quien las únicas manifestaciones de lupus eritematoso profundo se encontraron localizadas en la piel de la región mamaria y zona intermamaria. Debido a la baja frecuencia de dicha patología con esta localización peculiar nos abocamos a una revisión
Assuntos
Humanos , Feminino , Pessoa de Meia-Idade , Mama/patologia , Paniculite de Lúpus Eritematoso/diagnóstico , Lúpus Eritematoso Sistêmico/diagnósticoRESUMO
Se presenta un paciente en quien las únicas manifestaciones de lupus eritematoso profundo se encontraron localizadas en la piel de la región mamaria y zona intermamaria. Debido a la baja frecuencia de dicha patología con esta localización peculiar nos abocamos a una revisión (AU)